Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“PATINA tested maintenance ET/palbo/HER2-block after induction chemo/HER2-block for HR+/HER2+ MBC. mPFS 44 months DB09 may add the option of 1L T-DXd/P used continuously (no induction tested).
If both available, would you adopt the PATINA maintenance after induction T-DXd/P?”